I-Angiotensin receptor blockers (i-ARBs) ingenye yemithi umhlengikazi wakho wezokunakekelwa kwezempilo angabonisa ukuba aphathe ukucindezelwa kwegazi eliphezulu. Umfutho wegazi ophakeme , owaziwa nangokuthi unomfutho wegazi ophakeme, uthinta izingxenye ezimbili kwezintathu zabantu abadala futhi ukwandisa ingozi yesifo senhliziyo nokushaya , okuyizimbangela ezimbili ezihamba phambili zokufa e-United States.
Uchwepheshe wezokunakekelwa kwezempilo angancoma ukuthatha i-ARB ngokuhambisana nama-inhibitors e-ACE, olunye uhlobo lwemithi ejwayelekile eqondiswe umfutho wegazi ophakeme, noma iminye imithi.
Ngezinye izikhathi, iziguli ezithola ukukhwehlela njengomphumela ohlangothini lwe-ACE inhibitors, noma ungazibekezeli kahle, zingase zibekwe ama-ARB njengokunye.
Odokotela baphinde babone ama-ARB ukuphatha ezinye izimo zezempilo, kuhlanganise nokuhluleka kwenhliziyo, izifo ezingenayo isifo esingenasifo, nokuhluleka kwezinso ezigulini zesifo sikashukela.
Indlela Angiotensin Receptor Blockers Work
Le mithi ephakeme yengcindezi yegazi isebenza ngokuvimbela izenzo ze-hormone okuthiwa i-angiotensin II. Uma umzimba wakho ukhulula le hormone, imithwalo yegazi yakho ibe encane, evimbela ukugeleza kwegazi futhi iphakamisa ukucindezelwa kwegazi.
Ama-ARB anciphisa ukucindezelwa kwegazi ngoba ukuvimbela isenzo se-hormone kuvumela izitsha zakho zegazi ukuba ziphumule futhi zikhule, okuthuthukisa ukugeleza kwegazi.
Ama-Brand Brand kanye namaGenerics
Kukhona ama-ARB amaningana avamile anqunywe umfutho wegazi ophezulu, kuhlanganise:
- I-Edarbi (i- Azilsartan )
- Atacand ( Candesartan )
- I-Teveten (i- Eprosartan )
- I- Avapro ( I- rbesartan )
- I-Cozaar (i- Losartan )
- I-Benicar (i- Olmesartan )
- I-diovan (i- Valsartan )
- I-Micardis (i- Telmisartan )
Kubikwe Imiphumela Yecala
Abaningi be-Angiotensin receptor blockers ngokuvamile bayabekezela kahle abantu abaningi, futhi imiphumela emibi kakhulu ayifushane. Ezinye imiphumela emibi ezibikiwe zama-ARB zihlanganisa:
- Ukuzwa izinwele ezikhanyayo noma ukudilika
- Izinwele
- Izinkinga zeSinus, njengephunga eliphambene noma eligijima
- Ubuhlungu obubuyela emuva nangomlenze
- Izinkinga zesisu
- Uhudo olukhulu
- Ukulahlekelwa kwesisindo esibalulekile
Imiphumela emibi kakhulu engavamile, kodwa ingafaka:
- Indlela yokwelapha: imihlathi; ukukhathazeka ukuphefumula; noma ukuvuvukala kobuso bakho, kubandakanya izindebe, ulimi noma umphimbo
- Ukuhluleka kwezinso kanye / noma kwesibindi
- Nciphisa amangqamuzana amhlophe egazi
Ukuqapha
Nakuba i-ARB ngokuvamile ibhekwa njengokuphephile ukwelashwa kwengcindezi ephakeme yegazi, njengazo zonke imithi, ziza nokuqapha, okuvame ukufaka:
Ukusebenzisana. Ama-ARB angase ahlanganyele neminye imithi kanye nezithako, okufaka:
- Ubuhlungu be-NSAID buyanciphisa
- Ama-Antacids
- Lithium
- Amanye ama- diuretics
- Noma yimiphi imithi, amavithamini noma abathintela usawoti aqukethe potassium
- Imithi yokwelapha engaphezu kwe-counter for colds, umkhuhlane noma i-hayfever
Nguwe kuphela nodokotela wakho onganquma imithi efanele yokwelashwa kwengcindezi ephakeme yegazi. Qinisekisa ukuthi unikeza amagama kwanoma yimiphi iminye imithi kanye / noma izithako ozithathayo, kufaka phakathi izidakamizwa ezingaphezu kwe-counter.
Ukukhulelwa. Ama-ARB angabangela ukukhubazeka kokuzalwa. Uma ukhulelwe, noma uhlela nokukhulelwa, ungathathi ama-ARB. Khuluma nochwepheshe wakho wezempilo ngokuvimbela ukukhulelwa ngenkathi ethatha le mithi.
Utshwala. Uma uthatha i-ARB, khuluma nochwepheshe wezokunakekelwa kwezempilo ngaphambi kokuba udle utshwala.
Ehlanganiswe utshwala, le mithi inganciphisa kakhulu ukucindezeleka kwegazi, okwenza ugozi noma ukuphelelwa amandla.
ACE Inhibitors. Uma uhlangabezana nemiphumela emibi evela ku-ACE inhibitors, tshela udokotela wakho ngaphambi kokuthatha ama-ARB.
Umbiko wezokuphepha we-FDA
Uma usuqhuba ucwaningo kuma-ARB, kungenzeka ukuthi ubonile ulwazi kusukela ngo-2010 obonisa ukuthi ukuhlaziywa kwezivivinyo zemitholampilo bekutholile ukwanda, okwenziwe ngokuphawulekayo, kwengozi yokuba nomdlavuza kulabo abathatha le mithi. Ngenxa yalesi sikhathazo, i-US Food and Drug Administration (FDA) yenza ukubuyekezwa kokuphepha. Ngo-2011, i-FDA yafinyelela esiphethweni sayo futhi yabona ukuthi abantu abathatha ama-ARB abanalo ingozi enkulu yokuthola umdlavuza.
Imithombo:
Ukucindezelwa Kwegazi UK: Amangqamuzana e-Angiotensin Receptor Blockers - Imithi Yokucindezelwa Kwegazi
I-Mayo Clinic: I-Angiotensin II Receptor Blockers
Ukuphathwa Kwezokudla Nezidakamizwa zase-US: Akukho Ukwanda Kweengozini YeCancer ngeMithi Eminye Yokucindezeleka Kwegazi (2011)